title: Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): is prophylaxis required?
authors.forename: L
authors.initials: L
authors.lastname: Orlando
authors.forename: M
authors.initials: M
authors.lastname: Colleoni
authors.forename: F
authors.initials: F
authors.lastname: Nolè
authors.forename: R
authors.initials: R
authors.lastname: Biffi
authors.forename: A
authors.initials: A
authors.lastname: Rocca
authors.forename: G
authors.initials: G
authors.lastname: Curigliano
authors.forename: G
authors.initials: G
authors.lastname: Ferretti
authors.forename: G
authors.initials: G
authors.lastname: Peruzzotti
authors.forename: F
authors.initials: F
authors.lastname: de Braud
authors.forename: G
authors.initials: G
authors.lastname: Masci
authors.forename: A
authors.initials: A
authors.lastname: Goldhirsch
mesh_terms: D000328:Adult; D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D015994:Incidence; D007262:Infusions, Intravenous; D008875:Middle Aged; D012189:Retrospective Studies; D013923:Thromboembolism / Q000139:chemically induced* / Q000517:prevention & control; D020246:Venous Thrombosis / Q000139:chemically induced* / Q000517:prevention & control; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077235:Vinorelbine
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D014747:Vinblastine; D002945:Cisplatin; D000077235:Vinorelbine; D005472:Fluorouracil